Literature DB >> 23470342

Trastuzumab induced cardiomyopathy: wider implications for cardio-oncology.

Stuart D Rosen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23470342     DOI： 10.1136/heartjnl-2012-303495

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  3 in total

1.  First do no harm: population-based study shows non-evidence-based trastuzumab prescription may harm elderly women with breast cancer.

Authors:  Ya-Chen Tina Shih; Ying Xu; Wenli Dong; Fabrice Smieliauskas; Sharon Giordano; Yu Shen
Journal:  Breast Cancer Res Treat       Date:  2014-02-21       Impact factor: 4.872

Review 2.  Multimodality Advanced Cardiovascular and Molecular Imaging for Early Detection and Monitoring of Cancer Therapy-Associated Cardiotoxicity and the Role of Artificial Intelligence and Big Data.

Authors:  Jennifer M Kwan; Evangelos K Oikonomou; Mariana L Henry; Albert J Sinusas
Journal:  Front Cardiovasc Med       Date:  2022-03-15

3.  Cardiotoxicity of adjuvant chemotherapy with trastuzumab: a Japanese claim-based data analysis.

Authors:  Hiroshi Ohtsu; Akihiko Shimomura; Sakiko Miyazaki; Naohiro Yonemoto; Shinichiro Ueda; Chikako Shimizu; Kazuhiro Sase
Journal:  Open Heart       Date:  2022-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.